When Leronlimab is approved for the combo, NCCN ca
Post# of 148181
(Total Views: 438)
Posted On: 11/14/2019 4:51:53 AM
When Leronlimab is approved for the combo, NCCN can recommend the use of Leronlimab off-label for cancers where there is only a Phase I study, only to have proven safety and efficacy. The insurances accept the NCCN recommendations, and if a drug shows efficacy we immediately see how many people are responding, the NP received 10 emails in one day.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼